Is Eli Lilly Stock Running out of Steam?
The healthcare stock is up over 300% in five years and has a market cap of around $1 trillion.
Overview
Eli Lilly (NYSE: LLY) is an iconic company in the healthcare sector, with a robust, diverse business that enables it to continue adapting and growing. The craze around its GLP-1 drugs has unlocked the latest wave of growth for the business, propelling it to new heights.
But has the healthcare stock gotten too rich and too expensive to still be a good buy at its current valuation? It has generated incredible returns in recent years, and it trades at 40 times earnings; it isn't cheap. Has it run out of steam, or is the premium for this top growth stock justifiable?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.